Home/Filings/4/0001640455-22-000084
4//SEC Filing

Cole Hugh M 4

Accession 0001640455-22-000084

CIK 0001640455other

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 8:29 PM ET

Size

6.6 KB

Accession

0001640455-22-000084

Insider Transaction Report

Form 4
Period: 2022-08-01
Cole Hugh M
Chief Business Officer
Transactions
  • Award

    Common Stock

    2022-08-01+20,000126,716 total
  • Award

    Stock Option (Right to Buy)

    2022-08-01+40,00040,000 total
    Exercise: $2.97Exp: 2032-08-01Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The option will vest quarterly in 16 equal installments following August 1, 2022.

Issuer

Jounce Therapeutics, Inc.

CIK 0001640455

Entity typeother

Related Parties

1
  • filerCIK 0001604646

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 8:29 PM ET
Size
6.6 KB